PHKL Showcases Robotic Precision in Orthopaedic Care
KUALA LUMPUR, Malaysia, May 16, 2025 /PRNewswire/ -- Pantai Hospital Kuala Lumpur (PHKL) recently hosted its first-ever Ortho Experience Day, offering a rare, hands-on look at the hospital's cutting-edge MAKO Robotic Surgery System—a transformative tool in joint replacement procedures. Dr Rizal Abdul Rani, Orthopaedic Surgery Specialist, demonstrating with the Mako Surgical System ...
Xuanzhu Biopharm’s Xuanyuening® (BireociclibTablets) Approved for Dual Indications, Bringing Innovative Breakthroughs to Breast Cancer Treatment
HONG KONG, May 16, 2025 /PRNewswire/ -- On May 15, 2025, the latest announcement released by the National Medical Products Administration attracted widespread attention in the oncology community and the pharmaceutical market. Bireociclib tablets (trade name: Xuanyuening®), a Class 1 anti-tumor new drug independently developed by Xuanzhu Biopharmaceutical was officially approved for marketing. This innovative drug is indicated...
Second Head-to-head Phase 3 Study of Mazdutide versus Semaglutide Completes First Participant Dosing in Adults in China with Overweight or Obesity Accompanied Fatty Liver Disease (GLORY-3)
SAN FRANCISCO and SUZHOU, China, May 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic and other major diseases, announces that the first participant has been successfully dosed in GLORY-3, a Phase 3 clinical study of mazdutide...
Fotona® Appoints Jeff Duchemin as Group President and CEO
Duchemin brings global MedTech leadership experience to accelerate Fotona's next phase of growth DALLAS , May 15, 2025 /PRNewswire/ -- FotonaⓇ, a global leader in high-performing laser systems and energy-based devices for aesthetic, dental and gynecological applications, today announces the appointment of Jeff Duchemin as Group President and CEO. Duchemin brings decades of leadership experience in the...
CIT Srl Charts a Visionary Path in Supply Chain Digitalization with TraceLink’s Multienterprise Information Network Tower (MINT)
BOSTON, May 15, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent supply chain orchestration, today announced that CIT Srl, a rapidly growing contract packaging organization (CPO) based in the European Union, has selected TraceLink's Multienterprise Information Network Tower (MINT). Recognizing the pharmaceutical industry's accelerating shift toward...
Datasea Reports Third Fiscal Quarter 2025 Revenue of $10.4 Million Up 653.6% Year-over-Year
DTSS' AI-Powered Technology Serves as a Unifying Core Innovation for its5G Multimodal Digital Platform and Acoustic High-Tech Segment BEIJING, May 15, 2025 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a Nevada-based technology company specializing in 5G+AI multimodal digital solutions and acoustic high-tech innovations, today announced its financial results for...
Alamar Biosciences Expands NULISAseq™ CNS Disease Panel 120 with Groundbreaking Blood-Based Brain-Derived pTau Assays
First-of-its-kind panel includes brain-derived pTau217, pTau181, pTau231, and total tau assays to advance neurodegenerative disease research FREMONT, Calif., May 15, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced the expansion of its NULISAseq™ CNS Disease Panel 120 to include novel assays for brain-derived phosphorylated tau...
Intalight™ Receives CE Mark for Its Progressive DREAM OCT™ Swept Source Imaging
SAN JOSE, Calif. and SHANGHAI, May 15, 2025 /PRNewswire/ -- Intalight™, a company that develops advanced ophthalmic technologies and a leader in Optical Coherence Tomography (OCT) today announced it has received CE mark for its DREAM OCT™ platform. The CE mark serves as approval by the European Union (EU) to commercialize DREAM OCT,...
Dizal to Present Promising Clinical Data on Golidocitinib and DZD8586 for the Treatment of Lymphoma at the Coming International Hematology Conferences
The latest 2-year follow-up data on golidocitinib as a maintenance therapy for peripheral T-cell lymphoma (PTCL) patients who achieved tumor response after first-line systemic therapy will be presented orally at the 2025 ICML A pooled safety and efficacy analysis of two Phase I/II studies of DZD8586 in heavily pre-treated chronic lymphocytic leukemia/small...
Dalian Ruikang Rehabilitation Hospital Project of Neutech Group Commenced Construction
HONG KONG, May 15, 2025 /PRNewswire/ -- On 13 May 2025, the Dalian Ruikang Rehabilitation Hospital project, which is located in Neuedu Healthcare Technology Park at the North Section, Shuma Road, Dalian Hi-Tech Zone, commenced construction. As a key component of Neutech Group's five-in-one ecosystem of "education-healthcare-wellness and mind tour", the hospital will become an affiliated hospital of Dalian Neusoft University...
